Literature DB >> 23224909

Potential role of taurine in the prevention of diabetes and metabolic syndrome.

Masato Imae1, Toshiki Asano, Shigeru Murakami.   

Abstract

Metabolic syndrome is characterized by the cluster of a number of metabolic abnormalities in the presence of underlying insulin resistance. The prevalence of metabolic syndrome has steadily increased in all populations worldwide. Taurine (2-aminoethanesulfonic acid) is a sulfur-containing amino acid that is involved in a variety of physiological functions. Clinical and experimental studies show that taurine intake may be beneficial in the prevention of metabolic syndrome including diabetes, obesity, dyslipidemia, and hypertension. This article reviews the effect of taurine on all of the components of metabolic syndrome. In addition, the possible mechanisms by which taurine prevents diabetes and metabolic syndrome are also discussed. Further study is needed to determine the role of taurine in the development of metabolic syndrome in humans, because there is presently limited clinical data available.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224909     DOI: 10.1007/s00726-012-1434-4

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  25 in total

1.  Taurine protects cardiac contractility in killifish, Fundulus heteroclitus, by enhancing sarcoplasmic reticular Ca2+ cycling.

Authors:  Elenor F Henry; Tyson J MacCormack
Journal:  J Comp Physiol B       Date:  2017-05-23       Impact factor: 2.200

2.  Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.

Authors:  Masaaki Miyata; Tomoyuki Tanaka; Kazuho Takahashi; Akihiro Funaki; Yoshimasa Sugiura
Journal:  Amino Acids       Date:  2021-10-01       Impact factor: 3.520

3.  Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets.

Authors:  Yan Zheng; Uta Ceglarek; Tao Huang; Tiange Wang; Yoriko Heianza; Wenjie Ma; George A Bray; Joachim Thiery; Frank M Sacks; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2016-07-28       Impact factor: 5.958

4.  Taurine depresses cardiac contractility and enhances systemic heart glucose utilization in the cuttlefish, Sepia officinalis.

Authors:  Tyson J MacCormack; N I Callaghan; A V Sykes; W R Driedzic
Journal:  J Comp Physiol B       Date:  2015-12-07       Impact factor: 2.200

5.  High cysteine diet reduces insulin resistance in SHR-CRP rats.

Authors:  J Krijt; J Sokolová; J Šilhavý; P Mlejnek; J Kubovčiak; F Liška; H Malínská; M Hüttl; I Marková; M Křížková; M H Stipanuk; T Křížek; T Ditroi; P Nagy; V Kožich; M Pravenec
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

6.  Propargylglycine inhibits hypotaurine/taurine synthesis and elevates cystathionine and homocysteine concentrations in primary mouse hepatocytes.

Authors:  Halina Jurkowska; Martha H Stipanuk; Lawrence L Hirschberger; Heather B Roman
Journal:  Amino Acids       Date:  2015-03-13       Impact factor: 3.520

7.  Lean Fish Consumption Is Associated with Beneficial Changes in the Metabolic Syndrome Components: A 13-Year Follow-Up Study from the Norwegian Tromsø Study.

Authors:  Christine Tørris; Marianne Molin; Milada Cvancarova Småstuen
Journal:  Nutrients       Date:  2017-03-08       Impact factor: 5.717

8.  Impact of a Specific Amino Acid Composition with Micronutrients on Well-Being in Subjects with Chronic Psychological Stress and Exhaustion Conditions: A Pilot Study.

Authors:  Deborah Armborst; Christine Metzner; Birgit Alteheld; Norman Bitterlich; Daniela Rösler; Roswitha Siener
Journal:  Nutrients       Date:  2018-04-29       Impact factor: 5.717

9.  Consumption of lean fish reduces the risk of type 2 diabetes mellitus: a prospective population based cohort study of Norwegian women.

Authors:  Charlotta Rylander; Torkjel M Sandanger; Dagrun Engeset; Eiliv Lund
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

10.  Taurine Transporter Gene Expression in Mononuclear Blood Cells of Type 1 Diabetes Patients.

Authors:  Zaleida Napoli; Giuseppe Seghieri; Loria Bianchi; Roberto Anichini; Alessandra De Bellis; Ilaria Campesi; Ciriaco Carru; Stefano Occhioni; Angelo Zinellu; Flavia Franconi
Journal:  J Diabetes Res       Date:  2016-02-03       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.